LoginRegister
    Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20
    Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probeOpioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe
    Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampooRelief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo
    Dr Reddys yields positive results from phase 2b study of new psoriasis drugDr Reddys yields positive results from phase 2b study of new psoriasis drug
    USFDA okays marketing of first medical device IB-Stim to treat IBS painUSFDA okays marketing of first medical device IB-Stim to treat IBS pain
    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutinyRoche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny
    Merck, Rigaku partner to develop novel molecular structure analysis technologyMerck, Rigaku partner to develop novel molecular structure analysis technology
    Global forum to examine use of safer nicotine productsGlobal forum to examine use of safer nicotine products
    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRCMediclaim cannot be denied on presumption of pre-existing disease: NCDRC
    GSK Nucala wins USFDA approval for two new self-administration optionsGSK Nucala wins USFDA approval for two new self-administration options
    Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand servicesHealthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services
    Sanofi loses German patent case against Amgen over cholesterol drug PraluentSanofi loses German patent case against Amgen over cholesterol drug Praluent
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X